(Non-V600)BRAF Mutations Define a Clinically Distinct Molecular Subtype of Metastatic Colorectal Cancer

PURPOSE: Molecular diagnostic testing has become an integral part of the evaluation of patients with metastatic colorectal cancer (CRC). Expanded mutational testing, such as next-generation sequencing (NGS), often identifies mutations with unclear clinical or prognostic implications. One such exampl...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Clin Oncol
Главные авторы: Jones, Jeremy C., Renfro, Lindsay A., Al-Shamsi, Humaid O., Schrock, Alexa B., Rankin, Andrew, Zhang, Ben Y., Kasi, Pashtoon M., Voss, Jesse S., Leal, Alexis D., Sun, James, Ross, Jeffrey, Ali, Siraj M., Hubbard, Joleen M., Kipp, Benjamin R., McWilliams, Robert R., Kopetz, Scott, Wolff, Robert A., Grothey, Axel
Формат: Artigo
Язык:Inglês
Опубликовано: American Society of Clinical Oncology 2017
Предметы:
ORIGINAL REPORTS
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5549454/
https://ncbi.nlm.nih.gov/pubmed/28486044
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2016.71.4394
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы